S904 Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease After SARS-CoV-2 mRNA Vaccination

Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis

“…The details of the included studies are illustrated in Table 1 [14] , [15] , [16] , [17] , [18] , [19] , [20] , [21] , [22] . The details of the excluded studies with the reason for exclusion is shown in Supplementary Table 2 [23] , [24] , [25] , [26] , [27] , [28] , [29] , [30] , [31] , [32] , [33] , [34] , [35] , [36] , [37] , [38] , [39] , [40] , [41] , [42] , [43] , [44] , [45] , [46] , [47] , [48] .

Figure 1 PRISMA flow chart depicting the study screening and selection of the systematic review

…”

Current Evidence in SARS-CoV-2 mRNA Vaccines and Post-Vaccination Adverse Reports: Knowns and Unknowns

“…Generally, post-vaccination gastrointestinal occurrences were reported in 10–20% of cases in the mRNA vaccination studies, and these symptoms may be interpreted as an Inflammatory Bowel Disease (IBD) flare, resulting in patient concern and un-needed testing or therapy; however, a study showed that the mRNA vaccines do not seem to increase the risk of a disease flare in the vast majority of IBD patients [ 96 ].…”